CAPS
Capstone Holding Corp. NASDAQ Listed Jan 28, 1993$0.16
-6.79%
vs $0.18
Mkt Cap $869.5K
52w Low $0.16
0.0% of range
52w High $1.40
50d MA $0.21
200d MA $0.44
P/E (TTM)
-0.0x
EV/EBITDA
—
P/B
0.1x
Debt/Equity
2.3x
ROE
-170.5%
P/FCF
-0.2x
RSI (14)
42.30
ATR (14)
$0.02
Beta
-1.27
50d MA
$0.21
200d MA
$0.44
Avg Volume
4.9M
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
CIK (SEC)
Phone
602-286-5520
1275 West Washington Street · Alsip, IL 60803 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | AMC | 0.12 | 0.12 | +0.0% | 0.23 | -7.6% | -6.1% | -0.3% | -1.9% | -2.0% | -8.3% | — |
| May 28, 2026 | AMC | -0.19 | -0.21 | -10.5% | 0.31 | +1.3% | +4.9% | +7.5% | -2.9% | -5.0% | +5.4% | — |
| May 20, 2026 | AMC | -0.19 | -0.21 | -10.5% | 0.39 | -14.1% | -14.0% | +12.6% | -14.1% | -0.2% | -4.7% | — |
| Apr 15, 2026 | AMC | -0.13 | -2.68 | -1961.5% | 0.59 | +36.3% | -9.3% | -24.5% | +1.3% | -8.9% | +11.5% | — |
| Nov 18, 2025 | AMC | 0.12 | -0.35 | -391.7% | 0.90 | +3.3% | -1.6% | -10.7% | -5.5% | +8.3% | -2.8% | — |
| Aug 15, 2025 | AMC | -0.07 | -0.13 | -85.7% | 1.24 | +0.0% | -8.1% | -4.4% | -6.4% | -1.0% | +8.9% | — |
| May 15, 2025 | AMC | -1.10 | -0.47 | +57.3% | 1.66 | +66.3% | +47.6% | -14.7% | -5.7% | -1.0% | -2.1% | — |
| Apr 1, 2025 | AMC | -8.42 | -7.20 | +14.5% | 2.34 | +4.7% | +0.9% | -11.9% | -7.7% | -5.2% | +39.0% | — |
| Nov 14, 2024 | AMC | -8.42 | -6.33 | +24.8% | 3.20 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Sep 30, 2024 | AMC | — | 0.22 | — | 3.25 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Jun 29, 2024 | AMC | — | -2.42 | — | — | — | — | — | — | — | — | — |
| Mar 30, 2024 | AMC | — | -7.06 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2023 | AMC | — | -12.81 | — | — | — | — | — | — | — | — | — |
| Sep 29, 2023 | AMC | — | -3.86 | — | 7.50 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Jun 30, 2023 | AMC | — | -0.49 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | TNS | — | -7.07 | — | 18.50 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Dec 30, 2022 | TNS | — | -3.04 | — | 18.50 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Aug 13, 2019 | AMC | — | -10.00 | — | 5.00 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| May 13, 2019 | AMC | — | -20.00 | — | 15.00 | +0.0% | +0.0% | +0.0% | -33.3% | +0.0% | +50.0% | — |
| Aug 13, 2018 | AMC | — | 20.00 | — | 25.00 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
No analyst ratings available.
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Strout Gordon Lewis JrDir | — | Buy | 41,500 | $4.00 | $166K | 41,500 | -26.49% | -2.01% |
| Mar 7, 2025 | TOPOREK MICHAELDir | — | Buy | 41,750 | $4.00 | $167K | 41,750 | +5.03% | +5.37% |
| Mar 7, 2025 | Lipman Matthew E.Dir/Off | Chief Executive Officer | Buy | 41,750 | $4.00 | $167K | 2,570,412 | +2.81% | -5.39% |
8-K · 7.01
! Medium
Capstone Holding Corp. -- 8-K 7.01: Regulation FD Disclosure
Aug 27
8-K
Capstone Holding Corp. -- 8-K Filing
Aug 12
8-K · 2.02
!! High
Capstone Holding Corp. -- 8-K 2.02: Earnings Results
Aug 12
8-K · 8.01
!! High
Capstone Holding Corp. -- 8-K 8.01: Material Event / Announcement
Capstone Holding Corp. has until July 6, 2026, to raise its stock price above Nasdaq's minimum bid requirement or face delisting.
Jul 9
8-K · 1.01
! Medium
Capstone Holding Corp. -- 8-K 1.01: Equity Issuance
Capstone Holding Corp. amended its stock purchase agreement, potentially diluting existing shareholders through modified equity issuance terms and investor rights.
Jul 6
8-K · 1.01
!! High
Capstone Holding Corp. -- 8-K 1.01: Material Agreement
Capstone Holding Corp. secured a revolving credit facility with Stream Finance, LLC, providing increased financial flexibility for working capital and operational needs.
Jun 22
8-K · 1.01
!! High
Capstone Holding Corp. -- 8-K 1.01: Material Agreement
Jun 12
NT 10-Q
!! High
Capstone Holding Corp. -- Late Quarterly Report -- Distress Signal
May 15
8-K · 7.01
! Medium
Capstone Holding Corp. -- 8-K 7.01: Regulation FD Disclosure
Capstone Holding Corp. clarified shareholder concerns post-earnings, providing updates on convertible note obligations, working capital facility status, and reaffirming its fiscal 2026 guidance.
May 6
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
CAPS significantly diluted shareholders by voluntarily lowering the conversion price on $500,000 of debt from $1.10 to $0.57, indicating financial weakness and increasing conversion risk for existing equity holders.
Apr 16
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
Late annual report filing indicates CAPS faces regulatory compliance issues and potential financial distress, signaling increased risk of delisting and suggesting management may be unable to produce timely financial disclosures required by investors.
Mar 31
8-K · 2.01
!!! Very High
Capstone Holding Corp. -- 8-K 2.01: Acquisition Completed
Capstone Holding Corp. has completed an acquisition, requiring investors to review the attached financial statements of the acquired business to assess integration prospects and impact on future earnings.
Feb 17
Institutional (13F) — Top 4
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Ground Swell Capital, Llc | 10,448 | $3K | New | Jun 2026 |
| 2 | Kerr Financial Planning Corp | 75 | $690 | New | Jun 2026 |
| 3 | Ubs Group Ag | 61 | $41 | Reduced | Mar 2026 |
| 4 | Morgan Stanley | 2 | $2 | — | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 2
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 11,112 | $7K | Feb 2026 |
| 2 | Fidelity Series Total Market Index Fund | 3,674 | $1K | May 2026 |
Valuation
Market Cap
$870K
Enterprise Value
$9.5M
P/E (TTM)
-0.04x
Forward P/E
5.45x
PEG Ratio
0.00x
P/B
0.07x
P/S
0.01x
P/FCF
-0.19x
EV/EBITDA
—
Shares Out
5.3M
Financials (TTM)
Revenue
$60.2M
Net Income
-$22.1M
EBITDA
-$6.5M
Free Cash Flow
-$4.5M
Op Cash Flow
-$4.4M
EPS Basic
$-4.12
EPS Diluted
$-3.84
EPS Forward
$0.03
Gross Margin
25.4%
Op Margin
-6.0%
Net Margin
-36.7%
Balance Sheet
Total Assets
$51.4M
Total Liab.
$38.9M
Total Equity
$12.5M
Cash
$727K
LT Debt
$9.3M
Book Value/Sh
$2.34
Debt/Equity
2.32x
Current Ratio
1.00
Quick Ratio
0.26
Returns & Growth
ROE
-170.5%
ROA
-41.3%
ROIC
-4.0%
Rev Growth YoY
+4.5%
EPS Growth YoY
+88.2%
Price Returns
2W
-4.1%
1M
-7.7%
3M
-25.4%
6M
-74.7%
12M
-86.3%
Technicals
52W High
$1.40
52W Low
$0.16
50d MA
$0.21
200d MA
$0.44
RSI (14)
42.30
ATR (14)
$0.02
Beta
-1.27
Avg Volume
4.9M
Dividends
Div Rate
$0.13
Div Yield
31.4%
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 24, 2026 11:49pm
· Source: financialmodelingprep.com